Cardiovascular Department, John Hunter Hospital, Newcastle, NSW, Australia; Newcastle Centre of Excellence in Cardio-Oncology, Hunter Medical Research Institute, Hunter New England Local Health District, The University of Newcastle and Calvary Mater Newcastle, Newcastle, NSW, Australia.
Department of Medical Oncology, Flinders Medical Centre, Adelaide, SA, Australia; Flinders Health and Medical Research Institute, Flinders University, Adelaide, SA, Australia.
Heart Lung Circ. 2024 May;33(5):558-563. doi: 10.1016/j.hlc.2023.04.301. Epub 2023 Jun 14.
Cancer and cardiovascular disease (CVD) commonly coexist, with increasing evidence that long-term cancer survivors are more likely to die from CVD than the general population. Effective management of CVD and its risk factors requires identification of patients at increased risk who may benefit from early intervention and their appropriate monitoring across the disease trajectory. Improving outcomes requires new models of multidisciplinary cancer care supported by care pathways. Such pathways require a clear delineation of the roles and responsibilities of all team members and provision of appropriate enablers for their delivery. These include accessible point-of-care tools/risk calculators, patient resources, and the provision of tailored training opportunities for health care providers.
癌症和心血管疾病(CVD)通常同时存在,越来越多的证据表明,长期癌症幸存者死于 CVD 的风险高于一般人群。有效管理 CVD 及其风险因素需要识别处于高风险的患者,他们可能受益于早期干预及其在疾病轨迹中的适当监测。改善结果需要支持护理途径的多学科癌症护理新模式。这种途径需要明确界定所有团队成员的角色和责任,并为其提供适当的推动者。这些包括可及的即时护理工具/风险计算器、患者资源以及为医疗保健提供者提供量身定制的培训机会。